JP Stock MarketDetailed Quotes

ASKA Pharmaceutical Holdings (4886)

Watchlist

2603
-7-0.27%

20min DelayMarket Closed Apr 3 15:30 JST

74.87BMarket Cap14.47P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ASKA Pharmaceutical Holdings (4886) Key Financial Indicators

4886 Free Cash Flow (FCF)

Interested in knowing about ASKA Pharmaceutical Holdings's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

4886 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ASKA Pharmaceutical Holdings shows that the company's current ratio is 2.40, indicating healthy liquidity.

Currency: JPY

Quarterly

4886 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ASKA Pharmaceutical Holdings, the quick ratio is 1.06, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

4886 Return on Equity (ROE)

Want to learn more about the financial health of ASKA Pharmaceutical Holdings? The latest ROE figure is 2.66%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

4886 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ASKA Pharmaceutical Holdings, the total asset return on investment (ROA) is 1.63%.

Currency: JPY

Quarterly

4886 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check ASKA Pharmaceutical Holdings's latest financial report to see how their gross margin is doing - currently at 48.56%.

Currency: JPY

Quarterly

4886 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ASKA Pharmaceutical Holdings, the net profit margin is 8.56%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Middle East conflict spreads to the stock market! How should investors respond?

On April 3rd Eastern Time, the US-Iran conflict entered its 35th day. Iran rejected the US's 48-hour ceasefire proposal and launched a fierc Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm